Diabetes drug safe for HIV patients, study finds
(Medical Xpress)—People with HIV have an elevated risk of heart attacks, diabetes and insulin problems. To compound matters, there are not many drug options to prevent those secondary problems because of ...
HIV & AIDS
Mar 15, 2013 |
5 / 5 (1) |
0
|
US probes new pancreas risks with diabetes drugs (Update)
The U.S. Food and Drug Administration is looking into new evidence that suggests a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.
Medications
Mar 14, 2013 |
not rated yet |
0
Anti-ageing drug breakthrough
Drugs that combat ageing may be available within five years, following landmark work led by an Australian researcher. The work, published in the March 8 issue of Science, finally proves that a single anti-ageing enzyme in the ...
Medical research
Mar 08, 2013 |
5 / 5 (10) |
2
Risk of pancreatitis doubles for those taking new class of diabetes drugs
People who take the newest class of diabetes drugs to control blood sugar are twice as likely as those on other forms of sugar-control medication to be hospitalized with pancreatitis, Johns Hopkins researchers report.
Medications
Feb 25, 2013 |
5 / 5 (2) |
1
|
Diabetes drug may offer 'modest' weight loss for very obese teens
(HealthDay)—The drug Byetta, approved for adults with type 2 diabetes, appears to help severely obese teens lose some weight, a small study found.
Pediatrics
Feb 05, 2013 |
5 / 5 (1) |
0
|
Diabetes drug could hold promise for lung cancer patients
Ever since discovering a decade ago that a gene altered in lung cancer regulated an enzyme used in therapies against diabetes, Reuben Shaw has wondered if drugs originally designed to treat metabolic diseases ...
Cancer
Jan 29, 2013 |
not rated yet |
0
|
FDA approves 3 new drugs for type 2 diabetes
(HealthDay)—The U.S. Food and Drug Administration late Friday approved three new medications to help people battle type 2 diabetes.
Medications
Jan 26, 2013 |
5 / 5 (2) |
1
Drugs for diabetes: Scientists test the power of plants
(Medical Xpress)—New drugs to treat diabetes are being developed by scientists at the University of Greenwich.
Diabetes
Jan 16, 2013 |
5 / 5 (2) |
0
US panel backs novel diabetes pill from J&J (Update)
A panel of U.S. health experts ruled Thursday that an experimental diabetes drug from Johnson & Johnson is safe and effective, though lingering safety questions must be tracked over the long term.
Medications
Jan 10, 2013 |
not rated yet |
0
FDA staff: J&J diabetes drug may pose heart risk
Federal drug reviewers think Johnson & Johnson's experimental diabetes drug might bring heart risks because it raised cholesterol levels in patient testing.
Medications
Jan 08, 2013 |
not rated yet |
0
Study: Most-used diabetes drug works in different way than previously thought
A team, led by senior author Morris J. Birnbaum, MD, PhD, the Willard and Rhoda Ware Professor of Medicine, with the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University ...
Diabetes
Jan 06, 2013 |
5 / 5 (3) |
0
|
Healthy lifestyle during menopause may decrease breast cancer risk later on
Obese, postmenopausal women are at greater risk for developing breast cancer and their cancers tend to be more aggressive than those in lean counterparts. A University of Colorado Cancer Center study published in the December ...
Cancer
Dec 19, 2012 |
5 / 5 (1) |
0
C. diff scientists reveal potential target to fight infections
Researchers at Virginia Bioinformatics Institute at Virginia Tech have discovered how a common diarrhea-causing bacterium sends the body's natural defenses into overdrive, actually intensifying illness while fighting infection.
Diseases, Conditions, Syndromes
Nov 30, 2012 |
5 / 5 (1) |
0
|
EU OKs Bristol-Myers, AstraZeneca diabetes drug
(AP)—Drugmakers Bristol-Myers Squibb Co. and AstraZeneca PLC say their experimental diabetes pill has gotten its first major approval, in the European Union.
Medications
Nov 14, 2012 |
not rated yet |
0
Head-to-head trial of two diabetes drugs yields mixed results
A direct, head-to-head comparison of two of the newer treatments available for type 2 diabetes yielded mixed results.
Diabetes
Nov 06, 2012 |
5 / 5 (2) |
0
|
